跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,721 条关于
“hepatic cirrhosis”
全部
7,721
临床试验
6,880
药物
73
机构
5
资讯
763
7个月前
Bausch Health's Phase 3 RED-C Trials for Hepatic Encephalopathy Prevention Fail to Meet Primary Endpoint
7个月前
Bausch Health's Xifaxan Successor Fails Phase III Trials for Hepatic Encephalopathy Prevention
去年
Korro Bio's KRRO-110 Receives Green Light in Australia for AATD Trial
2年前
FDA Expands Furoscix Indication to Include NYHA Class IV Heart Failure Patients
去年
Rifaximin Monotherapy Superior to Lactulose in Preventing Hepatic Encephalopathy Recurrence
去年
Intercept Pharmaceuticals Voluntarily Withdraws OCALIVA from US Market Following FDA Request
去年
Yaqrit Advances L-ornithine Phenylacetate to Phase 3 for Acute Hepatic Encephalopathy Treatment
去年
Korro Bio Receives EMA Orphan Drug Designation for RNA Editing Therapy KRRO-110 in Alpha-1 Antitrypsin Deficiency
9个月前
Cirrhosis Reshapes Immune Microenvironment, Limiting Hepatocellular Carcinoma Immunotherapy Efficacy
去年
Bausch Health's RED-C Trials Evaluate Rifaximin Formulation for Hepatic Encephalopathy Prevention
第 1 页,共 77 页
上一页
下一页